vs
Side-by-side financial comparison of Marathon Bancorp, Inc. (MBBC) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Marathon Bancorp, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.9M, roughly 1.2× Q32 Bio Inc.). Q32 Bio Inc. runs the higher net margin — 2991.2% vs 22.3%, a 2968.9% gap on every dollar of revenue.
Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
MBBC vs QTTB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2M | $1.9M |
| Net Profit | $501.4K | $57.7M |
| Gross Margin | — | — |
| Operating Margin | 26.2% | — |
| Net Margin | 22.3% | 2991.2% |
| Revenue YoY | 41.7% | — |
| Net Profit YoY | 880.7% | 506.9% |
| EPS (diluted) | $0.19 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2M | $1.9M | ||
| Q3 25 | $2.1M | $-220.0K | ||
| Q2 25 | $1.9M | $-284.0K | ||
| Q1 25 | $1.7M | $-371.0K | ||
| Q4 24 | $1.6M | $0 | ||
| Q3 24 | $1.6M | $0 | ||
| Q2 24 | $1.6M | $0 | ||
| Q1 24 | $1.6M | $0 |
| Q4 25 | $501.4K | $57.7M | ||
| Q3 25 | $444.3K | $-7.4M | ||
| Q2 25 | $-332.0K | $-9.5M | ||
| Q1 25 | $148.4K | $-11.0M | ||
| Q4 24 | $51.1K | $-14.2M | ||
| Q3 24 | $174.9K | $-17.6M | ||
| Q2 24 | $85.8K | $-17.0M | ||
| Q1 24 | $-631.1K | $1.0M |
| Q4 25 | 26.2% | — | ||
| Q3 25 | 25.5% | 3444.1% | ||
| Q2 25 | -25.7% | 3229.2% | ||
| Q1 25 | 11.6% | 3296.0% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 13.4% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | -53.7% | — |
| Q4 25 | 22.3% | 2991.2% | ||
| Q3 25 | 20.7% | 3358.6% | ||
| Q2 25 | -18.9% | 3341.2% | ||
| Q1 25 | 8.9% | 2973.3% | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | -40.7% | — |
| Q4 25 | $0.19 | $4.70 | ||
| Q3 25 | $0.17 | $-0.60 | ||
| Q2 25 | $-0.13 | $-0.78 | ||
| Q1 25 | $0.07 | $-0.90 | ||
| Q4 24 | $0.02 | $2.63 | ||
| Q3 24 | $0.06 | $-1.46 | ||
| Q2 24 | $0.07 | $-1.42 | ||
| Q1 24 | $-0.31 | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.9M | $42.0M |
| Total Assets | $248.0M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.3M | ||
| Q3 25 | — | $49.0M | ||
| Q2 25 | — | $54.8M | ||
| Q1 25 | — | $65.5M | ||
| Q4 24 | — | $78.0M | ||
| Q3 24 | — | $89.1M | ||
| Q2 24 | — | $97.7M | ||
| Q1 24 | — | $115.5M |
| Q4 25 | $46.9M | $42.0M | ||
| Q3 25 | $46.3M | $-18.4M | ||
| Q2 25 | $45.7M | $-12.2M | ||
| Q1 25 | $32.0M | $-4.0M | ||
| Q4 24 | $31.7M | $5.7M | ||
| Q3 24 | $31.6M | $18.3M | ||
| Q2 24 | $31.3M | $33.5M | ||
| Q1 24 | $31.4M | $48.8M |
| Q4 25 | $248.0M | $61.8M | ||
| Q3 25 | $246.0M | $57.8M | ||
| Q2 25 | $238.8M | $66.1M | ||
| Q1 25 | $236.8M | $79.1M | ||
| Q4 24 | $217.9M | $92.3M | ||
| Q3 24 | $216.5M | $104.5M | ||
| Q2 24 | $219.3M | $124.2M | ||
| Q1 24 | $225.8M | $152.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $-6.2M |
| Free Cash FlowOCF − Capex | $1.4M | — |
| FCF MarginFCF / Revenue | 62.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 2.82× | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $-6.2M | ||
| Q3 25 | $464.0K | $-4.2M | ||
| Q2 25 | $1.4M | $-10.7M | ||
| Q1 25 | $849.0K | $-12.5M | ||
| Q4 24 | $113.6K | $-11.4M | ||
| Q3 24 | $945.2K | $-19.5M | ||
| Q2 24 | $416.6K | $-22.2M | ||
| Q1 24 | $-802.1K | $-14.6M |
| Q4 25 | $1.4M | — | ||
| Q3 25 | $456.6K | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | $773.2K | — | ||
| Q4 24 | $105.0K | $-11.4M | ||
| Q3 24 | $921.6K | $-19.6M | ||
| Q2 24 | $-1.8M | $-22.2M | ||
| Q1 24 | $-1.1M | — |
| Q4 25 | 62.3% | — | ||
| Q3 25 | 21.3% | — | ||
| Q2 25 | 66.0% | — | ||
| Q1 25 | 46.3% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 57.1% | — | ||
| Q2 24 | -118.5% | — | ||
| Q1 24 | -67.9% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 145.2% | — | ||
| Q1 24 | 16.2% | — |
| Q4 25 | 2.82× | -0.11× | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.72× | — | ||
| Q4 24 | 2.22× | — | ||
| Q3 24 | 5.40× | — | ||
| Q2 24 | 4.85× | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
